|
Feb 24
|
NeoGenomics to Participate in Upcoming Investor Conferences
|
|
Feb 19
|
NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations
|
|
Feb 19
|
NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Feb 19
|
Q4 2024 Neogenomics Inc Earnings Call
|
|
Feb 18
|
Why NeoGenomics (NEO) Shares Are Trading Lower Today
|
|
Feb 18
|
NeoGenomics (NEO) Tops Q4 Earnings Estimates
|
|
Feb 18
|
NeoGenomics: Q4 Earnings Snapshot
|
|
Feb 18
|
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets
|
|
Feb 18
|
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
|
|
Feb 17
|
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Feb 12
|
Q4 2024 Adaptive Biotechnologies Corp Earnings Call
|
|
Dec 30
|
NeoGenomics (NEO) Upgraded to Buy: Here's Why
|
|
Oct 8
|
NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|
|
Oct 8
|
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
|
|
Sep 11
|
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
|
|
Jul 29
|
NeoGenomics: Q2 Earnings Snapshot
|
|
Jul 29
|
NeoGenomics Reports Second Quarter 2024 Results
|
|
Jun 13
|
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
|
|
May 2
|
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
|
|
May 2
|
NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|